• Maxion Therapeutics expands its Cambridge headquarters and doubles the size of its offices and laboratory space• Howard Group provides tailored real estate solution to support the biotech’s growthCambridge, 20th May 2025: Leading regional property investor and developer Howard Group, is delighted to announce that pioneering biotechnology company Maxion Therapeutics has more than doubled its footprint at Unity Campus.Following its successful £58 million ($72 million) Series A funding round earlier this year, Maxion has signed a new lease for…
Partnership with SCINCO strengthens international sales and technical support channels in key region as part of ongoing global expansion
Cambridge, UK, 20 May 2025: CN Bio, a leading provider of Organ-on-a-chip (OOC) systems and solutions that accelerate drug discovery and development workflows, today announced a strategic partnership with SCINCO, a specialist scientific instrument company based in South Korea. The agreement is the latest milestone in CN Bio’s international expansion, amplifying the Company’s presence in major Asian and Pacific markets and broadening access to its predictive…
Creative Biolabs is at the forefront of creating stem cell therapy, working with researchers to make new scientific advancements.Induced pluripotent stem cells (iPSCs) contain the unprecedented possibility of differentiating into almost every cell in the body, which holds vast avenues for disease studying and developing novel therapies. Nonetheless, iPSC-based cell therapy is presently problematic. Issues like low reprogramming efficiency, genomic instability, risk of tumorigenicity, and failure in controlling differentiation encompass significant setbacks.Creative Biolabs, a US biotech firm…
Dozens of pharmaceutical companies and tech start-ups came together on Wednesday (14 May), to celebrate the one-year anniversary of a ‘super hub’ they have used to help accelerate their business.
The Deloitte Life Sciences Catalyst business lounge in Cambridge has helped hundreds of local and regional start-ups across the life sciences industry access a boardroom meeting space and state-of-the-art innovation hub for free.
The space, designed to be a regional hotspot for start-ups and world-leading businesses in the life sciences sector, was opened by Deloitte Cambridge in May 2024…
In an informative original blog - Amsbio reports how researchers at the University of Exeter Medical School have shed light on the role of microRNA - miR-483-5p in attenuating the detrimental effects of stress on brain function and anxiety-related behaviors.
MicroRNAs (miRNAs) are small RNA sequences that regulate gene expression and are implicated in some neuropsychiatric conditions. This published study focuses on miR-383-5p’s regulatory role in the amygdala, a region of the brain involved in emotional processing, known to play a crucial role in…
Established biotech leader with over 20 years’ experience including at OXB and LifeArc driving commercialization to support CGT downstream manufacturing
Michele Pedrocchi PhD appointed as Non-Executive Chair of the Board of Directors
Tozaro, an emerging technology provider in the field of cell and gene therapy manufacturing today announced the appointment of Dr. Jason Slingsby MBA as Chief Executive Officer, effective 22 April 2025. Jason will lead the Company’s long-term strategy, including commercialization of its Smart Polymer technology to enhance downstream manufacturing of viral…
3 July | Babraham Research Campus
What’s Next in Bio Innovation? At ON Helix 2024, we explored how novel therapeutic modalities, biomarker technologies, and TechBio are transforming drug discovery and development and how ecosystems enable scale-up of innovation. ON Helix 2025 will build on these insights, discuss progress and what’s next!
Harnessing the Body’s DefencesFrom protective antibodies to tools that can modulate the immune system, how will the new approaches drive disease prevention and treatment. …
Researchers at the John Innes Centre at Norwich Research Park have helped to solve a historical puzzle that could revolutionise the breeding of the humble pea and other legumes leading to improvements in their nutritional value and lessening the reliance on pesticides.
This landmark work, published in the journal Nature, comes at a time when peas and other legumes are being called upon both as sources of plant protein and as sustainable crops which can fix their own nitrogen. It could result in pea and other legume crops, needing less chemical fertiliser to grow, becoming more economically…
Global drug development consultancy Boyds has appointed a Vice President of Regulatory Affairs in response to growing demand for its specialist services and expertise.
With over 25 years’ experience in medicines development and regulatory affairs, Carmen Vieira joins Boyds to further strengthen its regulatory offering. Previously, Carmen was an independent regulatory science and strategy advisor, supporting the expedited development of medicines for start-ups, biotechs, and big pharma developers. Prior to this, she was Head of Regulatory Affairs & Non-Clinical at the Cell and Gene Therapy…
Isomerase has announced the launch of EvoSelect®, a machine learning-guided enzyme engineering platform designed to accelerate development timelines, enhance performance under industrial conditions, and reduce the cost and complexity of enzyme optimisation. EvoSelect® forms part of Isomerase’s broader IsoZym™ platform, an end-to-end offering that spans protein design, expression, and scale-up.
EvoSelect® harnesses evolutionary information embedded in enzyme families to generate novel sequences with improved properties. By analysing sequence alignments and evolutionary couplings - correlated…